| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/06/2023 | Akebia Therapeutics, Inc. | AKBA | Grant | Common Stock | 30k | $0.00 | $0 | | 06/06/2023 |
| 06/06/2023 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 45k | $1.20 | $54k | | 06/06/2023 |
| 09/23/2022 | Aravive, Inc. | ARAV | Grant | Stock Option (Right to Buy) | 97.1k | $0.92 | $88.8k | | 09/23/2022 |
| 06/08/2022 | Akebia Therapeutics, Inc. | AKBA | Grant | Common Stock | 13.7k | $0.00 | $0 | | 06/08/2022 |
| 06/08/2022 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 20.1k | $0.45 | $9k | | 06/08/2022 |
| 09/10/2021 | Aravive, Inc. | ARAV | Grant | Stock Option | 22.8k | $3.97 | $90.6k | | 09/10/2021 |
| 06/02/2021 | Akebia Therapeutics, Inc. | AKBA | Grant | Common Stock | 13.7k | $0.00 | $0 | | 06/02/2021 |
| 06/02/2021 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 20.1k | $3.37 | $67.7k | | 06/02/2021 |
| 09/15/2020 | Aravive, Inc. | ARAV | Grant | Stock Option | 15k | $5.99 | $89.8k | | 09/15/2020 |
| 09/15/2020 | Aravive, Inc. | ARAV | Grant | Stock Option | 15k | $5.99 | $90k | | 09/15/2020 |
| 06/05/2020 | Akebia Therapeutics, Inc. | AKBA | Grant | Common Stock | 13.7k | $0.00 | $0 | | 06/05/2020 |
| 06/05/2020 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 20.1k | $11.96 | $240.4k | | 06/05/2020 |
| 06/25/2019 | EyePoint Pharmaceuticals, Inc. | EYPT | Grant | Stock Option (Right to Buy) | 40k | $0.00 | $0 | | 06/25/2019 |
| 06/21/2019 | EyePoint Pharmaceuticals, Inc. | EYPT | Exercise | Deferred Stock Units | 6.7k | $0.00 | $0 | | 06/21/2019 |
| 06/06/2019 | Akebia Therapeutics, Inc. | AKBA | Grant | Common Stock | 13.7k | $0.00 | $0 | | 06/06/2019 |
| 06/06/2019 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 20.1k | $4.23 | $85k | | 06/06/2019 |
| 05/14/2019 | Aadi Bioscience, Inc. | ARPO | Grant | Stock Option (Right to Buy) | 430.5k | $1.04 | $447.7k | | 05/14/2019 |
| 05/14/2019 | Aadi Bioscience, Inc. | ARPO | Grant | Stock Option (Right to Buy) | 169.5k | $1.04 | $176.3k | | 05/14/2019 |
| 02/15/2019 | Aadi Bioscience, Inc. | ARPO | Grant | Stock Option (Right to Buy) | 215.3k | $3.27 | $704.1k | | 02/15/2019 |
| 12/12/2018 | KERYX BIOPHARMACEUTICALS INC | KERX | Disposition | Stock Option | 140k | $0.00 | $0 | | 12/12/2018 |
| 12/12/2018 | KERYX BIOPHARMACEUTICALS INC | KERX | Disposition | Common Stock | 30k | $0.00 | $0 | | 12/12/2018 |
| 12/12/2018 | Akebia Therapeutics, Inc. | AKBA | Grant | Common Stock | 11.2k | $0.00 | $0 | | 12/12/2018 |
| 12/12/2018 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 18.7k | $12.48 | $233.6k | | 12/12/2018 |
| 12/12/2018 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 11.2k | $15.26 | $171.4k | | 12/12/2018 |
| 12/12/2018 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 11.2k | $17.53 | $196.8k | | 12/12/2018 |
| 12/12/2018 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 11.2k | $10.05 | $112.9k | | 12/12/2018 |
| 12/12/2018 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 25k | $8.94 | $223.5k | | 12/12/2018 |
| 11/15/2018 | EyePoint Pharmaceuticals, Inc. | EYPT | Exercise | Employee Stock Option (right to buy) | 100k | $1.13 | $113k | | 11/15/2018 |
| 06/30/2018 | KERYX BIOPHARMACEUTICALS INC | KERX | Grant | Common Stock | 10k | $0.00 | $0 | | 06/30/2018 |
| 06/30/2018 | KERYX BIOPHARMACEUTICALS INC | KERX | Grant | Stock Options (right to buy) | 30k | $3.76 | $112.8k | | 06/30/2018 |
| 06/27/2018 | EyePoint Pharmaceuticals, Inc. | EYPT | Exercise | Deferred Stock Units | 12.5k | $0.00 | $0 | | 06/27/2018 |
| 06/21/2018 | EyePoint Pharmaceuticals, Inc. | EYPT | Grant | Employee Stock Option (right to buy) | 26.7k | $1.95 | $52k | | 06/21/2018 |
| 06/21/2018 | EyePoint Pharmaceuticals, Inc. | EYPT | Grant | Deferred Stock Units | 6.7k | $0.00 | $0 | | 06/21/2018 |
| 04/23/2018 | Aadi Bioscience, Inc. | ARPO | Grant | Stock Option (Right to Buy) | 144k | $3.59 | $517k | | 04/23/2018 |
| 12/15/2017 | EyePoint Pharmaceuticals, Inc. | EYPT | Grant | Deferred Stock Units | 12.5k | $0.00 | $0 | | 12/15/2017 |
|